BioMarin Pharmaceuticals
BMRN
BMRN
548 hedge funds and large institutions have $12.4B invested in BioMarin Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 86 funds opening new positions, 197 increasing their positions, 194 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
548
Holders Change
-6
Holders Change %
-1.08%
% of All Funds
7.93%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
86
Increased
197
Reduced
194
Closed
87
Calls
$152M
Puts
$112M
Net Calls
+$39.9M
Net Calls Change
+$53M
Top Buyers
Top Sellers
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$177M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$90.6M |
| 3 |
Barclays
London,
United Kingdom
|
-$58.4M |
| 4 |
State Street
Boston,
Massachusetts
|
-$57.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$55.5M |
